Marrow aplasia during high dose mebendazole treatment. (1986)

Peer-Reviewed Study · Fernández-Bañares F, González-Huix F, Xiol X, Catalá I, Miró J, López N, Casais L · 1986

Fernández-Bañares F et al., 1986: Case report of marrow aplasia developing 18 days into high-dose mebendazole treatment for a hepatic hydatid cyst in a patient with chronic liver disease. The authors note this was the sixth such patient described.

Eighteen days after beginning treatment he developed marrow aplasia which reverted to normal after the drug was stopped.

Fernández-Bañares F et al., 1986: Case report of marrow aplasia developing 18 days into high-dose mebendazole treatment for a hepatic hydatid cyst in a patient with chronic liver disease. The authors note this was the sixth such patient described. Case report; N=1; Spain (Hospital Princeps d'Espanya, Barcelona); mebendazole at large doses, exact mg/kg not stated in the abstract; 18 days to aplasia. Funder: not stated. Declared conflicts: none recorded. Comparator: none. The authors suggest dose and pre-existing liver disease were both contributing factors. Study type: case report.